Trial Profile
Dexmedetomidine as a sedative in paediatric intensive care.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 04 Aug 2017 New trial record